You are here

vorasidenib

Agios to Receive $1.1B Following FDA Approval of Vorasidenib

Contract Pharma

Wed, 08/7/24 - 11:26 am

Agios Pharmaceuticals

Agios cashes in on cancer drug again with $905M Royalty Pharma deal

BioPharma Dive

Tue, 05/28/24 - 10:33 pm

US, EU regulators start swift reviews of Servier glioma drug

Pharmaphorum

Wed, 02/21/24 - 11:09 am

Servier’s vorasidenib proves efficacy in tumor growth reduction

Clinical Trials Arena

Mon, 11/20/23 - 10:09 am

clinical trials

ASCO: French Pharma's Drug Slows Tumors in Brain Cancer Patients

BioSpace

Mon, 06/5/23 - 10:00 pm

Agios up as FDA gives Thermo Fisher glioma test breakthrough status

Pharmaforum

Tue, 06/16/20 - 10:35 am

Agios Pharmaceuticals